ID1

Across TCGA pan-cancer cohorts, ID1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ID1 data layer compared with 27 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher ID1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated ID1 expression acts as an unfavorable survival marker.

PDAC, LSCC, and LUAD are the cancer types where ID1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	All	0.162	0.567	.019	6	view →
LSCC	OS	Tertile	All	0.921	1.000	.035	4	view →
LUAD	OS	Tertile	III,IV	0.268	0.769	.026	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ID1–PDAC (DFS)

Open the PDAC breakdown →